E

Exelixis

D
EXEL
USD
-0.14
(-0.3978%)
Market Closed
84,721.00
حجم التداول
1.44
الربح لكل سهم
-
العائد الربحي
30.216
P/E
9,998,072,961.25
حجم السوق
اليوم
-0.3978%
1 اسبوع
-2.095%
1 شهر
33.600%
6 اشهر
66.945%
12 اشهر
63.938%
بداية السنة
46.072%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Exelixis

Sector:
Healthcare
Industry:
Biotechnology
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
هل تحتاج مساعدة او لديك استفسار؟